Dharminder Chahal

Dharminder Chahal appears in our data through filings on BioInvent International AB shares, published by Finansinspektionen. Over a trading history stretching from 23 February 2021 to 16 November 2022, the count stands at 6 filings.

The open-market record is one-sided, with 6 purchases worth €169k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2022, the count stands at 1 purchase and no sales.

The median purchase comes to €26k. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -1.3%. Past outcomes like these are no guarantee of what comes next.

On 17 November 2022 came the latest disclosure, an open-market purchase for €32k in BioInvent International AB. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.